NPCE

NeuroPace, Inc.

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Andrade LisaDirector
--2.9k shares
Grant / ExerciseJun 5, 2026
Disclosure amount unavailable2.9k shares
--
$17.26
Ryan ReneeDirector
--2.9k shares
Grant / ExerciseJun 5, 2026
Disclosure amount unavailable2.9k shares
--
$17.26
Kumar RakhiDirector
--2.9k shares
Grant / ExerciseJun 5, 2026
Disclosure amount unavailable2.9k shares
--
$17.26
Geiger UriDirector
--2.9k shares
Grant / ExerciseJun 5, 2026
Disclosure amount unavailable2.9k shares
--
$17.26
Fischer Frank MDirector
--2.9k shares
Grant / ExerciseJun 5, 2026
Disclosure amount unavailable2.9k shares
--
$17.26
Huennekens R ScottDirector
--2.9k shares
Grant / ExerciseJun 5, 2026
Disclosure amount unavailable2.9k shares
--
$17.26

News

zacks.comNPCE Receives FDA Approval for AI-Powered ECoG Assistant for Epilepsyzacks.comJun 2businesswire.comNeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meetingbusinesswire.comMay 29businesswire.comNeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Carebusinesswire.comMay 29zacks.comIs NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?zacks.comMay 27zacks.comNPCE Explains How NeuroPace's RNS System Makes Moneyzacks.comMay 27